The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Bristol-Myers Squibb - HIV R&D Assets

Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases.

Bristol-Myers Squibb - HIV R&D Assets Headquarter Location

345 Park Avenue

New York, New York, 10154-0028,

United States

800-332-2056

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Bristol-Myers Squibb - HIV R&D Assets's headquarters?

    Bristol-Myers Squibb - HIV R&D Assets's headquarters is located at 345 Park Avenue, New York.

  • What is Bristol-Myers Squibb - HIV R&D Assets's latest funding round?

    Bristol-Myers Squibb - HIV R&D Assets's latest funding round is Acquired Unit.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.